Cryptogenic Stroke in Relation to Genetic Variation in Clotting Factors and Other Genetic Polymorphisms Among Young Men and Women

Background and Purpose— The purpose of the present study was to compare the prevalences of genetic polymorphisms in persons with cryptogenic stroke with those among stroke patients with evidence of large-artery occlusive disease or an unequivocal cardioembolic source (noncryptogenic stroke). Methods— We compared the prevalences of genetic polymorphisms thought to be related to thrombi formation in young stroke patients with evidence of large-artery occlusive disease or an unequivocal cardioembolic source (noncryptogenic stroke; controls; n=79) with those in young stroke patients without such sources (cryptogenic stroke; cases; n=67). Common variations in the genes encoding factor V, prothrombin, angiotensin I–converting enzyme, 5,10-methylenetetrahydrofolate reductase, endothelial cell nitric oxide synthase, tissue plasminogen activator, plasminogen activator inhibitor–1, and fibrinogen were evaluated. We also compared the allele prevalence of these genes among all stroke patients with those among a large pool of historical controls assayed for these genes. Results— None of these genetic polymorphisms was statistically significantly related to cryptogenic stroke. With respect to a comparison of all ischemic stroke with historical controls, only the prevalence of tissue plasminogen activator D allele among stroke subjects was statistically significantly higher than that of the historical controls (P =0.0014). Conclusions— These findings generally do not support the hypothesis that genes associated with a prothrombotic state are risk factors among a subgroup of young people with stroke of undetermined cause. Except for the D tissue plasminogen activator allele, the findings also indicated that these genetic factors are unrelated, or only weakly related, to all ischemic stroke.

[1]  R. Hegele.  SNP judgments and freedom of association. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[2]  Vilmundur Gudnason,et al.  Localization of a susceptibility gene for common forms of stroke to 5q12. , 2002, American journal of human genetics.

[3]  J. Lalouel,et al.  Power and replication in case-control studies. , 2002, American journal of hypertension.

[4]  R. Junker,et al.  Symptomatic Ischemic Stroke in Full-Term Neonates: Role of Acquired and Genetic Prothrombotic Risk Factors , 2000, Stroke.

[5]  C. Mannhalter,et al.  The 4G/4G genotype at nucleotide position −675 in the promotor region of the plasminogen activator inhibitor 1 (PAI‐1) gene is less frequent in young patients with minor stroke than in controls , 2000, British journal of haematology.

[6]  N. Wenger,et al.  The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism. , 2000, Thrombosis research.

[7]  B. Damasceno,et al.  Inherited Thrombophilia as a Risk Factor for the Development of Ischemic Stroke in Young Adults , 2000, Thrombosis and Haemostasis.

[8]  E. Ringelstein,et al.  Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: relation to stroke etiology. , 1999, Neurological research.

[9]  A. von Eckardstein,et al.  Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. , 1999, Blood.

[10]  N. Wenger,et al.  The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. , 1999, Chest.

[11]  I. Perry.  Homocysteine and Risk of Stroke , 1999, Journal of cardiovascular risk.

[12]  O. Benavente,et al.  Stroke: part I. A clinical update on prevention. , 1999, American Family Physician.

[13]  D. Wilcken,et al.  Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. , 1998, Circulation.

[14]  M. Margaglione,et al.  Increased Risk for Venous Thrombosis in Carriers of the Prothrombin GA20210 Gene Variant , 1998, Annals of Internal Medicine.

[15]  T. Raghunathan,et al.  Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A) , 1998, Stroke.

[16]  A. Rumley,et al.  Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[17]  A. Hofman,et al.  Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study. , 1997, Circulation.

[18]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[19]  G. Murray,et al.  Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and stroke , 1995, Journal of hypertension.

[20]  H. Markus,et al.  Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. , 1995, Stroke.

[21]  P. Ridker,et al.  Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. , 1995, The New England journal of medicine.

[22]  P. Reitsma,et al.  High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) , 1995, Blood.

[23]  N. Carter,et al.  Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin 1-converting enzyme. , 1994, Journal of human hypertension.

[24]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[25]  J. Manson,et al.  Prospective study of endogenous tissue plasminogen activator and risk of stroke , 1994, The Lancet.

[26]  R. Poole,et al.  Left Atrial Spontaneous Echo Contrast Is Highly Associated With Previous Stroke in Patients With Atrial Fibrillation or Mitral Stenosis , 1993, Stroke.

[27]  Philippe Amouyel,et al.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.

[28]  J. Bogousslavsky,et al.  Ischemic stroke in patients under age 45. , 1992, Neurologic clinics.

[29]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[30]  G. Beck,et al.  Etiology of motor or sensory stroke: A prospective study of the predictive value of clinical and radiological features , 1991, Annals of neurology.

[31]  S. Humphries,et al.  Variation in the Promoter Region of the β Fibrinogen Gene Is Associated with Plasma Fibrinogen Levels in Smokers and Non-Smokers , 1991, Thrombosis and Haemostasis.

[32]  R. Hart,et al.  Hematologic disorders and ischemic stroke. A selective review. , 1990, Stroke.

[33]  Daniel B Hier,et al.  The Stroke Data Bank: design, methods, and baseline characteristics. , 1988, Stroke.

[34]  Tx Station.  Stata Statistical Software: Release 7. , 2001 .

[35]  G. Hallmans,et al.  Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke. , 2000, Stroke.

[36]  E. Taioli,et al.  The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels. , 1999, Thrombosis research.

[37]  R. Badenhop,et al.  A smoking–dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene , 1996, Nature Medicine.

[38]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[39]  David W. Hosmer,et al.  Best subsets logistic regression , 1989 .